FULCRUM THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.14 USD | +0.14% |
|
+4.39% | +5.78% |
| Mar. 18 | Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer | MT |
| Mar. 18 | Fulcrum Therapeutics, Inc. Announces Executive Changes | CI |
Chart calendar Fulcrum Therapeutics, Inc.
938e71d8.J72mpa8C_X3gczRXWd9AuDuHBQBJwCN4hyTY2LLn94M.S4_Xz9lFyQiPK2ARPZoryEnucHQvgXIaxhP1sOaxlPFr8pbr9WGIC5JFUw~d692378aa44b4b234c7f41c61cf573bd
Upcoming events on Fulcrum Therapeutics, Inc.
Past events on Fulcrum Therapeutics, Inc.
| 2024-04-02 10:40 am | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 2024-03-13 09:20 am | Leerink Partners Global Biopharma Conference |
| 2024-02-27 08:00 am | Q4 2023 Earnings Call |
| 2024-02-27 07:00 am | Q4 2023 Earnings Release |
| 2024-02-13 01:20 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-30 11:00 am | Piper Sandler Healthcare Conference |
| 2023-11-14 03:00 pm | Stifel Healthcare Conference |
| 2023-11-07 08:00 am | Q3 2023 Earnings Call |
| 2023-11-07 07:00 am | Q3 2023 Earnings Release |
| 2023-09-28 08:35 am | Cantor Global Healthcare Conference |
| 2023-08-03 08:00 am | Q2 2023 Earnings Call |
| 2023-08-03 07:02 am | Q2 2023 Earnings Release |
| 2023-06-08 09:00 am | Annual General Meeting |
| 2023-05-15 08:00 am | Q1 2023 Earnings Call |
| 2023-05-15 07:05 am | Q1 2023 Earnings Release |
| 2023-03-09 08:00 am | Q4 2022 Earnings Call |
| 2023-03-09 07:00 am | Q4 2022 Earnings Release |
| 2023-02-15 10:00 am | SVB Securities Global Biopharma Conference |
| 2023-01-11 07:30 pm | JP Morgan Healthcare Conference |
| 2022-12-08 09:10 am | Bank of America Biotech SMID Cap Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 8,82 5,69 55.13% | 19,2 16,8 14.18% | 6,34 7,35 -13.67% | 2,81 2,32 20.95% | 1,68 |
|
EBITDA Million USD | Released Forecast Spread | -82,2 -71,4 -15.1% | -69,2 -70,8 2.18% | -78,5 -87,5 10.2% | -110 -104 -5.23% | -108 -111 1.86% | -126 |
|
EBIT Million USD | Released Forecast Spread | -84,2 -79,3 -6.21% | -71,6 -73,9 3.15% | -81,1 -85,7 5.42% | -112 -108 -3.96% | -111 -112 1.12% | -124 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -82,7 -83,2 0.63% | -70,8 -73,5 3.65% | -80,8 -81,2 0.47% | -110 -108 -1.67% | -97,3 -99,6 2.29% | -116 |
|
Net income Million USD | Released Forecast Spread | -82,7 -67,1 -23.21% | -70,8 -73,2 3.21% | -80,8 -83,1 2.7% | -110 -108 -1.97% | -97,3 -101 3.66% | -113 |
|
EPS USD | Released Forecast Spread | -8,13 -2,52 -223.26% | -2,79 -2,82 0.92% | -2,29 -2,38 3.65% | -2,44 -2,44 -0.18% | -1,59 -1,65 3.44% | -1,72 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 09/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,06 3,21 57.33% | 2,59 3,94 -34.28% | 1,88 2,96 -36.51% | 1,18 2,54 -53.48% | 0,69 1,89 -63.76% | 0,30 0,98 -69.92% | 0,88 0,96 -8.03% | 0,76 1,05 -27.86% | 0,87 0,39 120.62% | 0,36 | 0,37 | 0,45 | 0,40 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -22,9 -32,0 28.3% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -23,6 -26,3 10.44% | -26,0 -24,9 -4.28% | -34,2 -27,5 -24.32% | -23,9 -26,6 10.33% | -28,0 -24,7 -13.54% | -27,9 -28,0 0.1% | -27,3 -28,3 3.59% | -27,4 -28,6 3.92% | -28,0 -29,2 4.28% | -29,6 | -30,5 | -31,2 | -32,1 | -36,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,5 -22,0 -6.68% | -25,9 -24,4 -6.13% | -34,1 -26,3 -29.49% | -23,7 -26,8 11.51% | -26,1 -24,4 -7.3% | -24,8 -26,1 4.98% | -23,8 -25,8 7.76% | -24,0 -26,0 7.48% | -24,8 -27,0 8.42% | -27,3 | -28,6 | -29,5 | -30,9 | -35,1 |
|
Net income Million USD | Released Forecast Spread | -23,5 -25,3 7.36% | -25,9 -24,8 -4.57% | -34,1 -27,1 -25.72% | -23,7 -26,6 10.66% | -26,1 -24,0 -8.72% | -24,8 -26,9 7.97% | -23,8 -26,8 11.1% | -24,0 -26,7 10.04% | -24,8 -26,6 6.94% | -27,1 | -27,9 | -28,5 | -29,4 | -35,1 |
|
EPS USD | Released Forecast Spread | -0,58 -0,66 12.12% | -0,64 -0,62 -3.78% | -0,83 -0,66 -25.76% | -0,51 -0,62 17.17% | -0,50 -0,49 -2.94% | -0,41 -0,46 10.31% | -0,38 -0,44 14.47% | -0,39 -0,44 10.34% | -0,40 -0,44 8.74% | -0,43 | -0,43 | -0,44 | -0,44 | -0,55 |
| Announcement Date | 03/03/22 | 09/05/22 | 11/08/22 | 08/11/22 | 09/03/23 | 15/05/23 | 03/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Fulcrum Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FULC Stock
- Calendar Fulcrum Therapeutics, Inc.
